PIK3R1 anticorps
-
- Antigène Voir toutes PIK3R1 (PI3K p85a) Anticorps
- PIK3R1 (PI3K p85a) (Phosphoinositide 3 Kinase, p85 alpha (PI3K p85a))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PIK3R1 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Immunogène
- PIK3R1 antibody was raised in Rabbit using a synthesized peptide derived from Internal of human PIK3R1 as the immunogen
- Isotype
- IgG
- Top Product
- Discover our top product PI3K p85a Anticorps primaire
-
-
- Indications d'application
- IHC: 1:50-1:100, IF: 1:100-1:500, ELISA: 1:5000
- Restrictions
- For Research Use only
-
- Concentration
- Lot specific
- Buffer
- PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Store at -20 °C for 1 year
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C for 1 year
-
- Antigène
- PIK3R1 (PI3K p85a) (Phosphoinositide 3 Kinase, p85 alpha (PI3K p85a))
- Autre désignation
- PIK3R1 (PI3K p85a Produits)
- Synonymes
- anticorps PI3CG, anticorps PI3K, anticorps PI3Kgamma, anticorps PIK3, anticorps AGM7, anticorps GRB1, anticorps p85, anticorps p85-ALPHA, anticorps PI3KA, anticorps AA414921, anticorps C530050K14, anticorps p50alpha, anticorps p55alpha, anticorps p85alpha, anticorps wu:fb65b05, anticorps phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma, anticorps phosphoinositide-3-kinase regulatory subunit 1, anticorps phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, anticorps phosphoinositide-3-kinase, regulatory subunit 1 (alpha), anticorps PIK3CG, anticorps PIK3R1, anticorps Pik3r1, anticorps Pik3cb, anticorps pik3r1
- Pathways
- TCR Signaling, Response to Growth Hormone Stimulus, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Hepatitis C, Protein targeting to Nucleus, VEGF Signaling, BCR Signaling, L'effet Warburg
-